Collectively, signaling protein analysis revealed a highly activated pathway of post-translational modification and protein transport to the rough endoplasmic reticulum (via GFM, MRPS12, RPS21, and SRP9), suggested circuitry to predict breast cancer outcomes [24] (Figure 2G). This evidence concerns the gene MRPS12 and breast carcinoma.